Cargando…

Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases: From Mechanistic Insights to Biomarkers

Phase I/II clinical trials of autologous hematopoietic stem cell transplantation (AHSCT) have led to increased safety and efficacy of this therapy for severe and refractory autoimmune diseases (AD). Recent phase III randomized studies have demonstrated that AHSCT induces long-term disease remission...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malmegrim, Kelen Cristina Ribeiro, Lima-Júnior, João Rodrigues, Arruda, Lucas Coelho Marlière, de Azevedo, Júlia Teixeira Cottas, de Oliveira, Gislane Lelis Vilela, Oliveira, Maria Carolina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250746/ https://www.ncbi.nlm.nih.gov/pubmed/30505303 http://dx.doi.org/10.3389/fimmu.2018.02602

Ejemplares similares

Editorial: Immune Profile After Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases: Where Do We Stand?
por: Malmegrim, Kelen Cristina Ribeiro, et al.
Publicado: (2020)

Editorial: Dietary habits, microbiota and autoimmune diseases
por: Pucca, Manuela Berto, et al.
Publicado: (2023)

Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy
por: Santana-Gonçalves, Maynara, et al.
Publicado: (2022)

Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients
por: Zanin-Silva, Djúlio C., et al.
Publicado: (2022)

Immunological Balance Is Associated with Clinical Outcome after Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes
por: Malmegrim, Kelen C. R., et al.
Publicado: (2017)

Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: Where do we stand? Volume II
por: Malmegrim, K. C. R., et al.
Publicado: (2022)

Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients
por: Jarduli‐Maciel, Luciana Ribeiro, et al.
Publicado: (2022)

Editorial: Intestinal Dysbiosis in Inflammatory Diseases
por: de Oliveira, Gislane Lelis Vilela, et al.
Publicado: (2021)

Long-Term Effects of Allogeneic Hematopoietic Stem Cell Transplantation on Systemic Inflammation in Sickle Cell Disease Patients
por: de Azevedo, Júlia Teixeira Cottas, et al.
Publicado: (2021)

Editorial: Microbiome in the growth and management of different types of cancer
por: Khan, Abdul Arif, et al.
Publicado: (2023)

Editorial: Women in microbiome in health and disease 2021
por: Pereira, Maria de Lourdes, et al.
Publicado: (2022)

Microbiota Modulation of the Gut-Lung Axis in COVID-19
por: de Oliveira, Gislane Lelis Vilela, et al.
Publicado: (2021)

Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo
por: Silvestre, Renata Nacasaki, et al.
Publicado: (2023)

Transcriptional profiling reveals intrinsic mRNA alterations in multipotent mesenchymal stromal cells isolated from bone marrow of newly-diagnosed type 1 diabetes patients
por: de Lima, Kalil A., et al.
Publicado: (2016)

Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies
por: Picanço-Castro, Virgínia, et al.
Publicado: (2020)

Microvascular Complications in Type 1 Diabetes: A Comparative Analysis of Patients Treated with Autologous Nonmyeloablative Hematopoietic Stem-Cell Transplantation and Conventional Medical Therapy
por: Penaforte-Saboia, Jaquellyne G., et al.
Publicado: (2017)

Intestinal Dysbiosis in Autoimmune Diabetes Is Correlated With Poor Glycemic Control and Increased Interleukin-6: A Pilot Study
por: Higuchi, Bruna Stevanato, et al.
Publicado: (2018)

New Horizons in the Treatment of Type 1 Diabetes: More Intense Immunosuppression and Beta Cell Replacement
por: Couri, Carlos E. B., et al.
Publicado: (2018)

Detection of Intestinal Dysbiosis in Post-COVID-19 Patients One to Eight Months after Acute Disease Resolution
por: Ferreira-Junior, Alexandre Soares, et al.
Publicado: (2022)

Membranous nephropathy in autologous hematopoietic stem cell transplant: autologous graft-versus-host disease or autoimmunity induction?
por: Abudayyeh, Ala, et al.
Publicado: (2015)

Functional Fermented Milk with Fruit Pulp Modulates the In Vitro Intestinal Microbiota
por: Borgonovi, Tais Fernanda, et al.
Publicado: (2022)

COVID-19 in the context of autologous hematopoietic stem cell transplantation for a patient with autoimmune disease
por: Alsuliman, Tamim, et al.
Publicado: (2022)

Resetting the T Cell Compartment in Autoimmune Diseases With Autologous Hematopoietic Stem Cell Transplantation: An Update
por: Lutter, Lisanne, et al.
Publicado: (2018)

Severe autoimmune pancytopenia after autologous hematopoietic stem cell transplantation for Hodgkin lymphoma
por: Fukui, Yuta, et al.
Publicado: (2022)

Life after Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis
por: Moraes, Daniela A, et al.
Publicado: (2021)

Mesenchymal Stromal Cells in Viral Infections: Implications for COVID-19
por: Rocha, José Lucas Martins, et al.
Publicado: (2020)

Correction to: Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies
por: Noronha, Nádia de Cássia, et al.
Publicado: (2019)

Detection of Alterations in the Gut Microbiota and Intestinal Permeability in Patients With Hashimoto Thyroiditis
por: Cayres, Leonardo César de Freitas, et al.
Publicado: (2021)

Remission of refractory Crohn's disease after autologous hematopoietic stem cell transplantation
por: Ruiz, Milton Artur, et al.
Publicado: (2015)

Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies
por: Noronha NC, Nádia de Cássia, et al.
Publicado: (2019)

Reconstitution of the immune system and clinical correlates after stem cell transplantation for systemic sclerosis
por: Kawashima-Vasconcelos, Marianna Y., et al.
Publicado: (2022)

Autologous hematopoietic stem cell transplantation in classical Hodgkin's lymphoma
por: Cortez, Afonso José Pereira, et al.
Publicado: (2011)

Autologous hematopoietic stem cell transplant for autoimmune diseases: evolution,evidence of efficacy, and real-world economics
por: Massey, Jennifer C., et al.
Publicado: (2019)

Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice
por: Yaochite, Juliana Navarro Ueda, et al.
Publicado: (2015)

Detection of Dysbiosis and Increased Intestinal Permeability in Brazilian Patients with Relapsing–Remitting Multiple Sclerosis
por: Pellizoni, Felipe Papa, et al.
Publicado: (2021)

Metabolic and Pancreatic Effects of Bone Marrow Mesenchymal Stem Cells Transplantation in Mice Fed High-Fat Diet
por: Bueno, Patricia de Godoy, et al.
Publicado: (2015)

Autoimmunity in Autologous Islet Transplantation
por: Ali, Khawla F., et al.
Publicado: (2018)

Emerging Role of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Pathogenesis of Haematological Malignancies
por: Cominal, Juçara Gastaldi, et al.
Publicado: (2019)

Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties
por: Yaochite, Juliana Navarro Ueda, et al.
Publicado: (2016)

Detection of Increased Plasma Interleukin-6 Levels and Prevalence of Prevotella copri and Bacteroides vulgatus in the Feces of Type 2 Diabetes Patients
por: Leite, Aline Zazeri, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_aujgjp154efioohf2m2v6vdbq7